Inari Medical Inc (NARI)
42.80
+0.96
(+2.29%)
USD |
NASDAQ |
May 07, 16:00
42.80
0.00 (0.00%)
After-Hours: 17:04
Inari Medical Research and Development Expense (Quarterly): 26.88M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 26.88M |
| December 31, 2023 | 22.89M |
| September 30, 2023 | 21.49M |
| June 30, 2023 | 21.08M |
| March 31, 2023 | 22.06M |
| December 31, 2022 | 20.41M |
| September 30, 2022 | 19.10M |
| June 30, 2022 | 18.57M |
| March 31, 2022 | 16.14M |
| December 31, 2021 | 18.73M |
| September 30, 2021 | 12.50M |
| Date | Value |
|---|---|
| June 30, 2021 | 11.63M |
| March 31, 2021 | 8.163M |
| December 31, 2020 | 6.536M |
| September 30, 2020 | 5.217M |
| June 30, 2020 | 3.628M |
| March 31, 2020 | 3.018M |
| December 31, 2019 | 2.709M |
| September 30, 2019 | 1.722M |
| June 30, 2019 | 1.58M |
| March 31, 2019 | 1.209M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.58M
Minimum
Jun 2019
26.88M
Maximum
Mar 2024
13.20M
Average
14.32M
Median
Research and Development Expense (Quarterly) Benchmarks
| Conmed Corp | 13.59M |
| SI-BONE Inc | 4.162M |
| Stereotaxis Inc | 2.212M |
| Electromed Inc | 0.107M |
| Myomo Inc | 0.878M |